Jump to content

NICE


observer
 Share

Recommended Posts

I've often thought that drugs companies should produce funding plans before they go ahead producing new drugs. I rather think that they produce the drugs and rely on emotional blackmail for sales. NICE have a very difficult job, how do you value a life given the finite resources available. With regards to liver cancer which is a really difficult one, I thought life expectancy was a matter of just a couple of months so this is clearly a fantastic drug if it extends life by six months, somebody I knew lasted six weeks between diagnosis and death. I suppose extending what could be a very short life expectancy, can be that it gives people the opportunity to put their affairs in order. I know that is what another friend of mine did when he had renal cancer, he had some serious financial problems but managed to sort them out so that his wife was OK when he died.

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
 Share

×
×
  • Create New...